Use of sulfadiazine in the prophylaxis of group A meningococcal carriers in Egypt.
D000293:Adolescent; D000328:Adult; D002353:Carrier State / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004534:Egypt; D006801:Humans; D008297:Male; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000517:prevention & control*; D008826:Microbial Sensitivity Tests; D009345:Neisseria meningitidis / Q000187:drug effects / Q000302:isolation & purification; D012111:Residence Characteristics; D013411:Sulfadiazine / Q000494:pharmacology / Q000627:therapeutic use*
D013411:Sulfadiazine